PILKOCOSPHARM is a Korea-based manufacturing company specializing in functional cosmetics, professional skin boosters, and medical device products. Leveraging in-house R&D capabilities, advanced formulation technologies, and OEM/ODM production systems, the company supplies a wide range of products to hospitals, aesthetic clinics, and global brand partners. By prioritizing high-purity active ingredients, stable delivery systems, and international quality standards, PILKOCOSPHARM provides export-ready products trusted in both domestic and overseas markets.

PILKOCOSPHARM collaborates with major Korean manufacturers such as Kolmar, Cosmecca, and Cosmax, and has continuously expanded its global network through partnerships in overseas markets including Uzbekistan, Vietnam, Kazakhstan, and Russia. Based on this cooperative structure, the company has established stable production and supply systems across the functional cosmetics and medical device sectors.
At this exhibition, PILKOCOSPHARM presents its skin booster lineup centered on its proprietary brand Mediciel, while actively seeking to expand domestic and international networks and identify strategic distribution partners. Through the exhibition, the company plans to increase engagement with hospitals, clinics, and overseas buyers, and to further define collaborative structures targeting global markets.

One of PILKOCOSPHARM’s representative products is the Mediciel PLLA Derma & Volume Powder, which is designed to deliver predictable treatment outcomes based on uniform particle sizes (20–30 μm and 30–50 μm). The formulation features a rapid suspension time of within 30 minutes, along with biodegradability and biocompatibility. Its structure is designed to consider both immediate volumizing effects provided by hyaluronic acid (HA) and long-term stimulation of collagen production through the PLLA component, enabling expectations of both immediate and mid- to long-term skin improvement effects following treatment.
PILKOCOSPHARM has currently designated Russia, Vietnam, and Kazakhstan as key growth markets. Russia is characterized by strong demand for functional cosmetics and aesthetic products, and PILKOCOSPHARM expanded its local market engagement by participating in the InterCHARM exhibition in Moscow last year. Kazakhstan is regarded as a market with high mid- to long-term growth potential due to increasing interest in Korean cosmetics and medical devices. In Vietnam, the company continues to strengthen partnerships based on its established customer base by participating annually in major industry exhibitions such as Medipharm and IDAX, thereby expanding its network.
Looking ahead, PILKOCOSPHARM plans to continuously participate in major medical device and dermatology-related exhibitions across the CIS region, the Middle East, Turkey, Vietnam, and Korea to reinforce its global presence. Through these efforts, the company aims to expand strategic partnerships and establish a stable global business structure in the functional cosmetics and skin booster sectors.